Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates
By A Mystery Man Writer
Description
A new paper presents preliminary evidence that a new vaccine candidate, designed to boost immunity in already immunized individuals, and containing the adjuvanted Beta spike variant protein antigen, can induce a potent cross-neutralizing antibody response in non-human primate models that is detectable for up to three months.
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://onlinelibrary.wiley.com/cms/asset/db94b40f-d243-46d5-b98d-03af9a225166/jmv29314-fig-0004-m.jpg)
Rational prediction of immunogenicity clustering through cross‐reactivity analysis of thirteen SARS‐CoV‐2 variants - Liang - 2024 - Journal of Medical Virology - Wiley Online Library
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://upload.wikimedia.org/wikipedia/commons/thumb/b/b4/World_map_of_share_of_people_who_received_all_doses_prescribed_by_the_initial_COVID-19_vaccination_protocol.png/510px-World_map_of_share_of_people_who_received_all_doses_prescribed_by_the_initial_COVID-19_vaccination_protocol.png)
COVID-19 vaccine - Wikipedia
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://pub.mdpi-res.com/vaccines/vaccines-10-00717/article_deploy/html/images/vaccines-10-00717-g001.png?1652235402)
Vaccines, Free Full-Text
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs43856-023-00302-z/MediaObjects/43856_2023_302_Fig4_HTML.png)
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-024-52499-1/MediaObjects/41598_2024_52499_Fig1_HTML.png)
Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41467-023-36908-z/MediaObjects/41467_2023_36908_Fig1_HTML.png)
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01318-5/MediaObjects/41591_2021_1318_Fig1_HTML.png)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://www.researchgate.net/publication/371080236/figure/fig2/AS:11431281162155728@1685156583857/Bivalent-CoV2-preS-dTM-AS03-D614-Beta-induces-broader-neutralization-of-variants-as.png)
Bivalent CoV2 preS dTM-AS03 (D614 + Beta) induces broader
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-024-52499-1/MediaObjects/41598_2024_52499_Fig1_HTML.png)
Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2
![Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-023-36908-z/MediaObjects/41467_2023_36908_Fig3_HTML.png)
Beta variant COVID-19 protein booster vaccine elicits durable cross- neutralization against SARS-CoV-2 variants in non-human primates
from
per adult (price varies by group size)